Role of the epithelium and acetylcholine in mediating the contraction to 5‐hydroxytryptamine in the mouse isolated trachea
- 1 April 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 141 (7) , 1159-1166
- https://doi.org/10.1038/sj.bjp.0705720
Abstract
1. The 5-HT receptor subtype that mediates bronchocontraction and the involvement of neuronal and non-neuronal acetylcholine was assessed in murine isolated tracheae. 2. Atropine (1-10 nM) caused a rightward shift of the methacholine concentration-effect curves (pA(2)=9.0) but reduced the maximum response to 5-HT, suggesting that 5-HT acts as an indirect agonist. The potency of 5-HT receptor agonists (alpha-methyl-5-HT approximately 5-HT>5-carboxamidotryptamine), together with the competitive antagonism of 5-HT by ketanserin (pA(2)=9.4), suggests the involvement of the 5-HT(2A) receptor. 3. While cholinergic twitch responses to electrical field stimulation were abolished by the fast sodium channel inhibitor tetrodotoxin (300 nM), as well as by combined blockade of N-, P- and Q-type voltage-operated calcium channels by omega-conotoxin GVIA (30 nM) and agatoxin IVA (100 nM), responses to 5-HT were unaffected. Similarly, botulinum toxin A (50 nM) inhibited EFS twitch responses, but not contractions to 5-HT. 4. Choline acetyltransferase immunoreactivity was localised to ganglia and nerve fibres as well as approximately half the epithelial cells in the preparation. Removal of the epithelial layer markedly attenuated the contractile response to 5-HT, but had no effect on contractions to either methacholine or EFS. 5. These findings suggest that 5-HT, acting at 5-HT(2A) receptors on mouse tracheal epithelial cells, stimulates these cells to release acetylcholine, which then causes contraction of airway smooth muscle. This phenomenon should be borne in mind in when interpreting studies of murine models of airway disease.Keywords
This publication has 19 references indexed in Scilit:
- Besides affecting intracellular calcium signaling, 2‐APB reversibly blocks gap junctional coupling in confluent monolayers, thereby allowing the measurement of single‐cell membrane currents in undissociated cellsThe FASEB Journal, 2003
- 2‐Aminoethoxydiphenyl borate (2‐APB) is a reliable blocker of store‐operated Ca2+entry but an inconsistent inhibitor of InsP3‐induced Ca2+releaseThe FASEB Journal, 2002
- The Non-neuronal Cholinergic System: an Emerging Drug Target in the AirwaysPulmonary Pharmacology & Therapeutics, 2001
- Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium storesNeuroscience, 2001
- How botulinum and tetanus neurotoxins block neurotransmitter release**This paper is dedicated to the memory of Heiner Niemann.Biochimie, 2000
- 5-HT modifiers as a potential treatment of asthmaTrends in Pharmacological Sciences, 2000
- The Effects of 2-Aminoethoxydiphenyl Borate, a Novel Inositol 1,4,5-Trisphosphate Receptor Modulator on Myometrial ContractionsBiochemical and Biophysical Research Communications, 1999
- Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholineBritish Journal of Pharmacology, 1999
- Multiple Serotonin Receptors: Too Many, Not Enough, or Just the Right Number?Neuroscience & Biobehavioral Reviews, 1997
- The effect of inhaled 5‐hydroxytryptamine (5‐HT, serotonin) on airway calibre in man.British Journal of Clinical Pharmacology, 1986